Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jazz Pharma Plc (NQ: JAZZ ) 101.07 +0.50 (+0.50%) Streaming Delayed Price Updated: 11:46 AM EDT, Jul 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Jazz Pharma Plc < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Europe's High: Irish GPs Against Pot, Switzerland-Spain Share Data On Cannabis Clubs & More October 20, 2023 Denmark: Medical Marijuana Pilot Program Experience 90% Growth In 12 Months Via Benzinga Topics Cannabis Exposures Cannabis Jazz Pharmaceuticals Explores Asset Sale Option, Possibly Cannabinoid Business: Report October 20, 2023 Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is reportedly exploring strategic options comprising a potential sale. Via Benzinga 2 Top Biotech Stocks to Buy in October October 03, 2023 Growth catalysts lie ahead for both of these players. Via The Motley Fool 5 Genius Safe Stocks to Buy for the 4th Quarter of 2023 October 02, 2023 These highly profitable, time-tested companies can deliver for their shareholders in any economic climate. Via The Motley Fool 4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip September 30, 2023 An 18% decline in the Nasdaq Composite from its all-time high means bargains still abound. Via The Motley Fool Topics Stocks Exposures US Equities Where Jazz Pharmaceuticals Stands With Analysts September 29, 2023 Via Benzinga Expert Ratings for Jazz Pharmaceuticals August 10, 2023 Via Benzinga Where Jazz Pharmaceuticals Stands With Analysts July 11, 2023 Via Benzinga Is Axsome Therapeutics Stock a Screaming Buy? June 15, 2023 The biotech could be staring down an enormous commercial opportunity. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023 September 29, 2023 Via Benzinga 3 Cannabis Stocks That Should Be on Every Investor’s Radar This Fall September 27, 2023 The cannabis industry is a quiet place where huge upside potential is building up. As more regions legalize, cannabis stocks can soar. Via InvestorPlace Topics Cannabis Exposures Cannabis 3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall September 20, 2023 Even with higher for longer interest rates, drug discovery moves on. That’s why it’s still a good time to look for biotech stocks to buy. Via InvestorPlace 7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom September 19, 2023 Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as rescheduling approaches for weed. Via InvestorPlace Topics Cannabis Exposures Cannabis Cannabis Industry Changes As Marijuana Rescheduling Looms September 15, 2023 As the Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the top... Via Benzinga Topics Cannabis Exposures Cannabis NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years September 12, 2023 NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035. Via Benzinga Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030 August 26, 2023 These two businesses may be sound, but generating returns in this industry has been tough, with no light at the end of the tunnel. Via The Motley Fool Topics Cannabis Exposures Cannabis Epidiolex Counterpart Debuts In Brazil's Cannabis Market As Its Maker Eyes TSX IPO August 23, 2023 Verdemed, a pharmaceutical company known for producing cannabis-derived products, has received five fresh approvals from the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância... Via Benzinga Topics Cannabis Exposures Cannabis Jazz Pharmaceuticals' Neuroscience Pipeline Readouts In Focus: Analyst Lowers Price Target August 14, 2023 Cantor Fitzgerald analyst Charles C. Via Benzinga Cannabis Stock Gainers And Losers From August 11, 2023 August 11, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Jazz Pharmaceuticals Reports Q2 2023 Net Income Of $104.4M, What About Total Revenues? August 09, 2023 Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced its financial results for the second quarter of 2023, along with its outlook for the remainder of the year. Via Benzinga 3 Biotech Stocks You’ll Regret Not Buying Soon August 08, 2023 These top biotech stocks are must-buys with huge potential, leading the industry with high-rewards for investors. Via InvestorPlace 10 Health Care Stocks With Whale Alerts In Today's Session August 08, 2023 Via Benzinga GOP Rep. Blasts FDA Over CBD Inaction During Historic Hearing: The Agency Wants More Money To Do Its Job July 28, 2023 For the first time, Congress officially addressed the impact of the U.S. Food and Drug Administration’s (FDA) inaction regarding the regulations of CBD products. Via Benzinga FDA, Get It Done! Says Senator In Bipartisan Push To Regulate CBD Products Prior To Committee Hearing July 21, 2023 A bipartisan group of U.S. lawmakers reintroduceda measure on Wednesdaythat aims to secure theFood and Drug ... Via Benzinga Divided GOP Helps This State Dodge Bullet From The Pot Lobby, Says Anti-Marijuana Group July 10, 2023 Is the battle for medical marijuana legalization in North Carolina over for this year? Some groups say yes, some say know, here is what happened. Via Benzinga 4 Unequaled Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip July 08, 2023 Bargains are hiding in plain sight with the Nasdaq Composite still well below its November 2021 record-closing high. Via The Motley Fool Jazz Pharmaceuticals Sues FDA Over Approval Of Rival Product, Calls It 'Unlawful' June 23, 2023 Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has filed suit against the FDA for approving Avadel Pharmaceuticals Plc's (NASDAQ: AVDL) Lumryz (sodium oxybate extended-release) for cataplexy or excessive day Via Benzinga 10 Cannabis Stocks That Could Go Sky High In 2023 June 18, 2023 With cannabis legalization gaining momentum, investing in cannabis presents a lucrative opportunity. Investors may want to explore cannabis stocks to enhance their portfolios. Here are the top 10... Via Talk Markets How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities June 17, 2023 The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators... Via Talk Markets Stocks That Hit 52-Week Lows On Tuesday June 13, 2023 On Tuesday, 32 companies reached new 52-week lows. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.